[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Quantinuum Stock Has Tremendous Potential, but It Isn’t Cheap

Quantinuum (QNT), the quantum company in which Honeywell (HON) has a 48% stake, has tremendous potential. That's because QNT's technology is quite advanced and has already been validated to a large extent, according to multiple investment banks that recently published bullish notes about QNT stock.

Further, quantum technology itself is likely to be very useful and may be revolutionary, while the U.S. government is backing quantum in general and Quantinuum in particular, and QNT stock has a great deal of positive momentum at this point.

Fundamentals

See More
  • Market Capitalization, $K 201,931,744
  • Shares Outstanding, K 539,708
  • Annual Sales, $ 36,751 M
  • Annual Income, $ 7,711 M
  • EBIT $ 10,568 M
  • EBITDA $ 16,935 M
  • 60-Month Beta 0.41
  • Price/Sales 5.31
  • Price/Cash Flow 11.07
  • Price/Book 21.97

Options Overview Details

View History
  • Implied Volatility 29.01% (+0.15%)
  • Historical Volatility 25.23%
  • IV Percentile 76%
  • IV Rank 60.97%
  • IV High 35.00% on 04/07/26
  • IV Low 19.66% on 08/15/25
  • Expected Move (DTE 5) 4.25 (1.14%)
  • Put/Call Vol Ratio 0.47
  • Today's Volume 5,964
  • Volume Avg (30-Day) 6,598
  • Put/Call OI Ratio 0.76
  • Today's Open Interest 115,927
  • Open Int (30-Day) 121,326
  • Expected Range 369.90 to 378.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 35 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $5.57
  • Number of Estimates 10
  • High Estimate $5.77
  • Low Estimate $5.34
  • Prior Year $6.02
  • Growth Rate Est. (year over year) -7.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
325.98 +14.78%
on 06/03/26
375.15 -0.27%
on 07/02/26
+45.89 (+13.98%)
since 06/02/26
3-Month
320.52 +16.73%
on 05/05/26
375.15 -0.27%
on 07/02/26
+26.21 (+7.53%)
since 04/02/26
52-Week
269.77 +38.69%
on 09/26/25
391.29 -4.38%
on 03/02/26
+77.30 (+26.04%)
since 07/02/25

Most Recent Stories

More News
Quantinuum Stock Has Tremendous Potential, but It Isn’t Cheap

Quantinuum is well-positioned to soar in the long term, but it could sink in the medium term.

QNT : 74.56 (-4.91%)
HON : 229.86 (+3.66%)
BMWKY : 22.9500 (+3.80%)
AMGN : 374.15 (+3.55%)
3 Nasdaq 100 Stocks to Research Further

3 Nasdaq 100 Stocks to Research Further

AAPL : 308.63 (+4.84%)
KDP : 33.30 (-0.21%)
AMGN : 374.15 (+3.55%)
Amgen (AMGN) Stock Is Up, What You Need To Know

Amgen (AMGN) Stock Is Up, What You Need To Know

AMGN : 374.15 (+3.55%)
Quantum Computing Has a New Publicly Traded Giant. Trade Quantinuum (QNT) Volatility With 2X Leverage

Quantinuum has emerged as a leading quantum computing company following its IPO, and bullish traders are using the Tradr 2X Long QNT Daily ETF (QNTU) to seek amplified exposure to its momentu

QUBT : 9.05 (-4.03%)
QBTS : 22.53 (-4.13%)
QNT : 74.56 (-4.91%)
JPM : 334.47 (+0.12%)
QNTU : 20.71 (-10.19%)
RGTI : 17.94 (-3.96%)
AMGN : 374.15 (+3.55%)
QNT Stock Alert: Here's Why Quantinuum Just Scored Multiple 'Buy' Ratings

Quantinuum stock rips higher as Wall Street analysts assign bullish price targets after the post-IPO quiet period. Here’s how high QNT shares could realistically fly in 2026.

QNT : 74.56 (-4.91%)
HON : 229.86 (+3.66%)
AMGN : 374.15 (+3.55%)
2 Healthcare Stocks to Consider Right Now and 1 We Brush Off

2 Healthcare Stocks to Consider Right Now and 1 We Brush Off

MEDP : 557.60 (+2.58%)
GDRX : 3.05 (-0.33%)
AMGN : 374.15 (+3.55%)
The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch.

The iShares Nasdaq Biotechnology ETF (IBB) is trading just 1.47% below its 52-week high, signaling a potential multi-year sector breakout.

IBB : 195.70 (+2.93%)
VRTX : 528.04 (+6.03%)
GILD : 131.27 (+4.21%)
AMGN : 374.15 (+3.55%)
How Is Biogen’s Stock Performance Compared to Other Biotech Stocks?

Biogen has recently outperformed its industry peers, and analysts remain reasonably upbeat about the stock’s prospects.

IBB : 195.70 (+2.93%)
AMGN : 374.15 (+3.55%)
BIIB : 216.12 (+3.04%)
2 S&P 500 Stocks with Competitive Advantages and 1 Facing Challenges

2 S&P 500 Stocks with Competitive Advantages and 1 Facing Challenges

COP : 104.73 (+1.46%)
HIG : 137.85 (+2.96%)
AMGN : 374.15 (+3.55%)
AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

VESALIUS-CV Subgroup Results Show Repatha ® Reduces Risk of First Major Cardiovascular Events by 29% in People Living with High-Risk Diabetes

AMGN : 374.15 (+3.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 70%. The market has entered overbought territory.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 390.16
2nd Resistance Point 382.66
1st Resistance Point 378.40
Last Price 374.15
1st Support Level 366.64
2nd Support Level 359.14
3rd Support Level 354.88

See More

52-Week High 391.29
Last Price 374.15
Fibonacci 61.8% 344.87
Fibonacci 50% 330.53
Fibonacci 38.2% 316.19
52-Week Low 269.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.